Worldwide Clinical Laboratory Testing Market

Diagnostic tests or clinical laboratory tests have a very important role in the diagnosis of any disease and in the healthcare system. These tests are the basis of most of the medical decisions. The laboratory tests are mainly of three types, clinical or routine tests, anatomic pathology tests and esoteric tests. Diagnostics tests have a little wider coverage than the clinical laboratory tests.

Payors play an important role in this industry as they are the ones who reimburse the cost of the tests to the laboratories. There are both government and private payors and include healthcare insurers also. Each of these payors operates differently and also have different share in the reimbursements depending upon the countries. The laboratory testing industry is also supported by the In Vitro Diagnostic industry which supplies all the instruments used in the laboratory tests.

International Laboratory Accreditation Cooperation (ILAC) is the international body for accrediting these laboratories. Each country or region has an independent accrediting body which is ultimately a member of or affiliated to the ILAC, to provide accreditation to the laboratories.

With the increasing awareness about early detection and prevention of diseases and the aging of the world population, the industry is poised for rapid growth. There are various players in this industry. Most players are limited to a country or a region but a few operate more widely. For example, Quest Diagnostic and LabCorp in USA, LAbco Diagnostics in Europe, Sonic Healthcare (SHL), Symbion Health, and Healthscope (HSP) in Austraila.

This report analyzes the global clinical laboratory market and various aspects of the market like reimbursement market and In Vitro Diagnostic market. It has also covers various countries and the respective markets, their issues and growth drivers. The report also profiles the leading players of this industry.